醫療保健供應商優先考慮AI合作夥伴關係
醫療保健供應商越來越多地尋求與第三方供應商合作，61%的組織傾向於這種定製化解決方案而非內部開發。美國食品藥品監督管理局已批准1300多種AI醫療設備，其中超過一半在過去三年中獲得批准。然而，調查顯示，77%的技術領導者認為不成熟的AI工具是採用的主要障礙。
Health care providers are shifting their AI strategy toward partnerships. A McKinsey study found 61% of health care organizations intend to partner with third-party vendors to develop customized generative AI solutions, favoring collaboration over in-house building or off-the-shelf products. This strategy aims to address specific clinical and operational needs while avoiding implementation failures common in complex health care environments.
Adoption faces significant hurdles despite rising AI utilization. The FDA reports approval of over 1,300 AI-enabled medical devices, with more than 50% authorized in the past three years. However, 77% of surveyed technology leaders cite immature AI tools as a major barrier to adoption. Furthermore, 72% of leaders prioritize reducing caregiver burden, while 53% focus on workflow efficiency, highlighting a demand for administrative tools over purely clinical applications.